Tocilizumab (Avtozma)

Avtozma (Tocilizumab) is a biologic medicine that suppresses an overactive immune system in order to treat rheumatoid arthritis, giant-cell arteritis and some types of juvenile arthritis.

Avtozma works by blocking a receptor on the surface of cells that’s related to the body’s immune response: the interleukin-6 receptor (IL-6R).

This medication is often given in combination with methotrexate.

It can take 6-12 weeks to feel the effects of Avtozma.

Taking Avtozma

Avtozma is available as an injection (Avtozma SC) and as an intravenous infusion (Avtozma IV). The injection can be done quickly at home. The infusion is done every 4 weeks at a specialized infusion clinic.

Important Tests and Risks

Science

Safety

Avtozma Video

Watch rheumatologist Dr. Andy Thompson introduce Avtozma in a short 3-minute video:

Resources

Avtozma IV Quick Reference Guide
Avtozma SC Quick Reference Guide
Pregnancy & Medications Quick Reference Guide

DIN

  • 02562030 (IV)
  • 02562049 (IV)
  • 02562022 (IV)
  • 02562065 (SC - Autoinjector)
  • 02562057 (SC - Syringe)